2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(pent-4-en-1-yl)hept-6-enoic acid, 97%, 1g

2,4-Dichlorobenzofuro[3,2-d]pyrimidine, 97%, 500mg

Benzyl 3-(2-methoxy-2-oxoethylidene)azetidine-1-carboxylate, 95.0%, 1g

Rebastinib, 99.91%, 50mg

2-adamantanone, min. 99%, for synthesis, 100 g, glass packaging

(S)-2-Isopropylamino-3-methyl-1-butanol>97.0%(GC)5g

1-(4-Fluorophenyl)-2-thiourea, 95.0%, 25g

7-Aminoheptanoic acid hydrochloride, 95.0%, 25g

2-(4-Chloro-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 10g

DMT-Cl, >98%, 5g

5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester, 95.0%, 5g

2-(4-Bromo-2-chloro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

Methyl thiosalicylate, 97.0%, 1g